Translational Development Acquisition Corp.
TDAC
$10.60
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9,073.77% | 970.40% | 725.05% | 390.92% | 85.40% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5,953.85% | -354,543.75% | -237,431.25% | -244,100.00% | -- |
| Change in Net Operating Assets | 150.95% | -1,846.64% | -24,815.00% | -21,864.00% | -22,096.67% |
| Cash from Operations | 28.55% | -3,114.81% | -- | -1,083,000.00% | -425,650.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -50.80% | -12.41% | 380.71% | 961.43% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 91,614.67% | -- | -- | -- |
| Cash from Financing | -99.89% | 66,700.04% | 250,532.29% | 501,264.57% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -193.65% | -179.76% | -152.72% | 387.07% | 218,150.00% |